[1] 贺威,李馨,王秋雨,等.老年急性ST段抬高型心肌梗死患者急诊介入术后慢血流或无复流危险因素及预后分析[J].中华老年心脑血管病杂志,2024,26(7):742-745.
[2] 王亚芳,朱烨然,荣素然,等.介入治疗策略对老年急性ST段抬高型心肌梗死患者预后研究[J].中华老年心脑血管病杂志,2024,26(6):610-613.
[3] 王要鑫,秦啸鸣,刘洁云,等.达格列净对ST段抬高心肌梗死非糖尿病老年患者急诊经皮冠脉介入术术后心肌微循环及近期预后的影响[J].中国合理用药探索,2024,21(8):91-96.
[4] 贾海燕,张卫锋,贾辛未,等.老年急性心肌梗死患者冠状动脉介入治疗不同时机的预后分析[J].中华老年心脑血管病杂志,2023,25(12):1386-1388.
[5] Fatemeh B, Mohammad KA, Azam S, et al.Clinical, laboratory, and procedural predictors of slow flow/no reflow phenomenon after emergency percutaneous coronary interventions in ST-elevated myocardial infarction.[J]. Egypt Heart J, 2024, 76(1):146.
[6] Hbaieb M.A., Charfeddine S., Bosquet L., et al. The effect of early cardiopulmonary rehabilitation combined with melatonin supplementation in patients with myocardial infarction treated by a primary percutaneous coronary intervention[J]. Arch Cardiovasc Dis, 2024, 117(1S):s117.
[7] 王岚,马玉良,朱天刚,等.ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后左心室整体长轴应变损减对远期预后的影响[J].中国循环杂志,2024,39(5):451-455.
[8] Bagheri J, Jameie M, Saryazdi ZD, et al.Coronary Artery Bypass Graft Surgery After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction.[J]. Heart Lung Circ, 2023, 32(10):1257-1268.
[9] Razi K, Shanjot B, Farshad H, et al.Assessing the Safety of Early Repatriation for Stable ST-Segment Elevation Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention[J]. CJC Open, 2024, 6(11):1289-1298.
[10] 苗雅敬,王晓旭,汪雁博,等.溶栓后早期经皮冠状动脉介入对急性ST段抬高型心肌梗死患者心肌灌注及左心功能的影响[J].中华超声影像学杂志,2024,33(2):98-105.
[11] 雷金义,夏裕,欧晓红.芪参益气滴丸对急性心肌梗死经皮冠状动脉介入术后患者临床疗效的影响[J].广州中医药大学学报,2024,41(4):835-839.
[12] Rouhollah H, Mobina F, Morteza HM, et al.Timing percutaneous coronary interventions and cardiovascular events in non-ST-elevation myocardial infarction patients.[J]. Am J Cardiovasc Dis, 2024, 14(1):40-46.
[13] Hesse K, Egred M, Zaman A, et al.Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Complex Coronary Artery Disease: Long-term Clinical Outcomes from a High-volume Center.[J]. Heart Views, 2023, 24(3):141-147.
[14] 刘凯,陈园园,陈海燕,等.达格列净对急性心肌梗死合并糖尿病患者经皮冠状动脉介入治疗后糖代谢和心功能的影响[J].西北药学杂志,2024,39(3):189-193.
[15] 杨凯,江成功,宋和鉴,等.左西孟旦对急性心肌梗死患者PCI治疗后心肌灌注和心电图指标的影响[J].现代生物医学进展,2024,24(13):2542-2545,2501.
[16] 贾莉,刘阳,张文超,等.替格瑞洛联合左西孟旦对急性心肌梗死PCI后患者的疗效[J].河北医药,2024,46(1):83-86.
[17] 吴立测,叶丁容,林汉明.急性ST段抬高型心肌梗死患者不同时间段行介入治疗对患者预后的影响[J].黑龙江医药,2023,36(4):896-899.
[18] 李钰,陈寒艳,林桂芬.不同治疗时间窗对急性前壁心肌梗死患者行急诊冠脉介入治疗的效果[J].中国卫生标准管理,2024,15(2):121-125.
[19] 高炯,吕文娟.经皮冠状动脉介入不同时机对急性心肌梗死患者MACE发生率及血清心肌酶谱变化研究[J].山西卫生健康职业学院学报,2024,34(4):31-33.
[20] 贾海燕,张卫锋,贾辛未,等.急性心肌梗死不同冠脉介入治疗时机的预后分析[J].医学研究与教育,2023,40(2):25-32.
[21] 陈仕毅,王筱梅,刘羽,等.介入时机对非ST段抬高型心肌梗死中危患者基质金属蛋白酶及左心室重构影响[J].创伤与急危重病医学,2023,11(3):202-205.
[22] Shi B, Ma XP, Ye CY, et al.Timing of percutaneous coronary intervention and risk of new-onset acute ischemic stroke in non-ST elevation myocardial infarction: A retrospective cohort study insight into the National Inpatient Sample Database (2016-2019).[J]. Health Sci Rep, 2024, 7(9):e70029.
[23] Manoj K, Shafaqat A, Priya H, et al.C-14 Impact of timing of Percutaneous Coronary Intervention on outcomes of Acute Myocardial Infarction[J]. J Soc Cardiovasc Angiogr Interv, 2024, 3(5S):101645.
[24] 王亦灵,刘海波,罗溶.即时介入治疗对中高危非ST段抬高型心肌梗死患者预后的影响[J].临床心血管病杂志,2023,39(9):688-693.
[25] 滕玉欢,杨鸥,王妍,等.不同时间窗对急性心肌梗死患者行冠状动脉介入临床疗效及其预后的影响[J].中国老年学杂志,2023,43(14):3336-3338.
[26] 卜云涛,丁超,刘文秀,等.尼可地尔联合缺血后适应对STEMI患者急诊PPCI心肌血流灌注及预后的影响[J].中南医学科学杂志,2024,52(4):628-631.
[27] Rajesh K, Cormac O'Connor, Jathinder K, et al. Activation of PPCI team in the octogenarian and nonagenarians population: Real-world single-centre experience[J]. Open Heart, 2021, 8(2):e001709.
[28] Waiel A, Mahboob A, Khagendra D.Meta-Analysis Comparing OutcomesofInvasive Versus Conservative Strategyin Octogenarians With Non-STSegment Elevation Acute Myocardial Infarction[J]. Am J Cardiol, 2021, 160:130-132.
[29] 刘正东,蒋慧,李璨.经皮冠状动脉介入治疗冠心病的疗效研究[J].中外医疗,2024,43(13):69-72,89.
[30] Alzamara M, Akinti O, Nworie K, et al.Abstract 14962: Rate of 30-Day Readmission and Economic Burden of Sickle Cell Disease Patients Who Underwent Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Procedure for ST Elevation Myocardial Infarction[J]. Circulation, 2023, 148(Suppl_1):A14962.
[31] 李靖凯,董晓龙,卢锋,等.冠状动脉搭桥术与经皮冠状动脉介入术治疗左主干冠状动脉病变的效果比较[J].临床医学,2024,44(2):9-12.
[32] 高红丽,陈晖,梁思文,等.首次急性心肌梗死急诊冠状动脉介入术后静息心率对预后的影响[J].心肺血管病杂志,2023,42(8):783-787.
[33] 杨体霞,程昭栋,李峰,等.经皮冠状动脉介入治疗急性ST段抬高型心肌梗死与急性非ST段抬高型心肌梗死患者的临床对比[J].中国临床保健杂志,2023,26(4):535-539.
[34] 李建华,王利楠,徐鹏飞.不同时机行经皮冠状动脉介入治疗对急性心肌梗死患者预后的影响[J].中国实用医刊,2024,51(9):40-43.
[35] 李江锋,胡东涛,李丽.AMI患者急性前壁AAMI患者介入治疗时机对其MACCE事件及心功能的影响[J].哈尔滨医药,2024,44(3):84-86.
[36] 张国艳,杨森林,李晨阳.烟酰胺注射液联合替格瑞洛用于急性心肌梗死经皮冠状动脉介入治疗后的效果[J].中国药物应用与监测,2024,21(4):324-327.
[37] 吕莹,严自强,徐慧欣,等.替格瑞洛联合急诊经皮冠脉介入术治疗急性心肌梗死的效果及安全性[J].中国临床药学杂志,2024,33(2):100-103.
[38] 谢爱娟. 替罗非班辅助急性心肌梗死急诊经皮冠状动脉介入术的应用研究[J].山西医药杂志,2024,53(16):1208-1212.
[39] 杜泽华,齐培,武甲龙,等.左西孟旦在急性心肌梗死经皮冠状动脉介入术后患者中的应用效果[J].河南医学研究,2024,33(3):532-535.
[40] M. Sadeghian.No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction Treated With Ticagrelor Versus Clopidogrel Plus Eptifibatide: A Randomised Clinical Trial[J]. Heart Lung Circ, 2024, 33(S4):s564. |
